Special Payouts, Sticky Yields, and a Printer Stock Worth a Second Look

The market spent yesterday glued to Iran headlines and oil futures.

Meanwhile, a fresh batch of 8-K filings dropped, and a couple of them deserve more attention than they're getting. One regulated utility teased a special dividend.

A printer business goes ex-dividend today with a yield that's hard to ignore. And a protein giant quietly reaffirmed its payout into a tough commodity setup. Here's what matters before the open.

Energy Crisis (Sponsored)

The Energy Shock Is Here

Tanker traffic through Hormuz has collapsed.

LNG capacity is offline.

Countries are already rationing fuel.

Energy shocks don’t stay contained—they spread through the entire economy.

As a market technician, I’ve studied these cycles for decades, and they always lead to monetary response—and currency pressure.

See the four companies positioned for this shift.

Media

Fox Is Turning Live Sports Into a Cross-Border Growth Engine

Fox Corporation (NASDAQ: FOXA) just secured a multi-year deal to broadcast NFL games across its platforms in Mexico starting with the 2026 season.

The agreement gives Fox a broad package of live games, playoff coverage, major football events, and original NFL programming built for Mexican audiences.

For Fox, live sports remain one of the strongest anchors in media.

While entertainment viewing keeps fragmenting across apps and platforms, big sports rights still pull reliable audiences, advertisers, and subscriber interest.

Mexico Becomes a Key Sports Market

Fox is not just adding another programming block. It is strengthening its presence in a country where NFL interest is already meaningful and where major sports content can help deepen viewer loyalty.

If you strip away the rights language, the move is simple. Fox is using the NFL to build a stronger media position in Mexico, not just to replay U.S. content in another market.

Sports Remain Fox’s, Power Lane

Live sports give Fox something advertisers still care about: appointment viewing. NFL content also creates weekly habits, repeat engagement, and room for local shows that keep audiences connected beyond game day.

Fox now has a stronger bridge into Latin America’s sports media market.

If the rollout works, you get a company that uses premium sports rights to expand its reach, strengthen its platforms, and build a more durable international media business.

FOX currently trades at $68 and pays a dividend of $0.56 per share, a yield of 0.82%.

Consumer

Global Social Media Rules Are Turning Into an Apple Opportunity

Apple (NASDAQ: AAPL) is expanding child safety controls for iPhone and iPad users as governments around the world move toward tougher rules on children’s access to social media.

Apple is turning a global regulatory shift into a product advantage.

As social media platforms face more pressure over young users, Apple is strengthening the family layer of its ecosystem and making the iPhone feel more manageable for parents.

Family Controls Become a Product Feature

Parents are no longer looking only at screen quality, camera upgrades, or app performance.

Safety settings, age controls, and healthier digital habits are becoming part of the device-buying decision.

For you, the business point is simple. Apple is making its hardware and software feel safer for families at a time when governments are forcing the entire tech industry to rethink children’s online access.

Regulation Creates a New Opening

Countries including Australia, the UK, parts of India, Indonesia, and several European markets have been moving toward tighter social media limits for younger users.

Apple sits in a different position because it controls the device layer, not just one app.

That gives your reader a clearer company angle. Apple can become the gatekeeper that helps families manage digital access before children even reach social media platforms.

If Apple executes this well, you get a company turning family safety into another growth signal across iPhone, iPad, services, and long-term customer retention.

AAPL currently trades at $290 and pays a dividend of $1.04 per share, a yield of 0.36%.

A-Rated Tech (Sponsored)

Elon’s next AI move?

Elon Musk may be turning SpaceX into an AI infrastructure giant.

Louis Navellier says this could accelerate a massive megatrend he calls “Project Apex.”

But the bigger opportunity may not be SpaceX.

Louis found a little-known tech company with over 30,000 patents tied to Elon’s AI vision — and his system just gave it an A-rating.

See the Project Apex stock Louis says to watch before June 11.

Pharma

Amgen Wants to Change the Rhythm of Obesity Treatment

Amgen (NASDAQ: AMGN) is pushing deeper into the booming weight-loss drug market with MariTide, its most important obesity medicine in development.

MariTide gives Amgen a clearer path into one of the fastest-growing areas in global healthcare.

Obesity treatment has become a major pharma battleground, and a drug that reduces how often patients need injections could give Amgen a real commercial opening.

Dosing Becomes the Differentiator

Current market leaders require weekly injections, which means patients may receive dozens of shots a year.

Amgen is testing whether MariTide can be administered at far lower doses, including once every 8 or 12 weeks, in a switch study.

For you, the business point is easy to understand.

Amgen is not trying to enter the obesity market with a copycat product; it is trying to win with convenience, persistence, and a cleaner patient routine.

A Large Program Is Now Underway

Amgen already has nine global phase III studies running across obesity and related conditions, including sleep apnea, cardiovascular disease, and heart failure.

Additional diabetes studies are planned for 2026, giving MariTide a wider development path than weight loss alone.

That puts your attention on scale. Amgen is building MariTide as a platform opportunity across metabolic health, not as a narrow single-use drug.

If Amgen can prove MariTide works with less frequent dosing, you get a company with a differentiated asset that could reshape its pipeline story and add a major new business driver.

AMGN currently trades at $345 and pays a dividend of $10.08 per share, a yield of 2.92%.

Ares Capital (ARCC) appears on this week's increase list according to analysts. 

HP Inc. (HPQ) bumped its payout ahead of today's ex-dividend date. Yield now stands near 4.73%. 

Cigna (CI) joined the increase list according to analysts's tracker. 

Halliburton (HAL) lifted its quarterly payout. 

Medtronic (MDT) filed an 8-K on June 3 referencing a dividend increase.

No dividend decreases turned up in the SEC EDGAR feed over the past 7 days. We will flag any that surface ahead of next week's send.

IPO Filing Shock (Sponsored)

BREAKING UPDATE: Elon Musk Just Filed the SpaceX IPO

It was supposed to be confidential...

But it's become the worst-kept secret on Wall Street.

Right now, 21 banks are lining up to underwrite the $1.75 TRILLION deal - JPMorgan, Goldman Sachs, Morgan Stanley.

June is the target date for launch...

That gives everyday Americans a small window to get positioned before Wall Street insiders gobble up all the profits.

Click here to claim your Pre-IPO SpaceX "Access Code"

Everything Else

• 🏦 A free report names seven lesser known stocks showing the same growth catalysts as mega cap tech at cheaper valuations.

• 🏛️ Iran says ticket allocation for World Cup withdrawn days before tournament.

• 📊 LNG demand in Asia recovers from Iran shock as China buys.

• 💵 US military launches new strikes on Iran after Apache downing.

• ✈️ Congress has backed Iran war powers resolutions. Now what?